With the analysis among 9,143 patents, we discovered top 452 key players by total patent application. F. Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals, Inc., Amgen Research (Munich) GmbH are dominant in this area. They take 21.82% of the total patent filing.
F. Hoffmann-La Roche Ltd.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 705
Amgen Research (Munich) GmbH
Hessen, Germany
Patent: 438
California, United States
Patent: 345
California, United States
Patent: 307
Hovedstaden, Denmark
Patent: 303
Chugai Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 273
ZURICH, Switzerland
Patent: 252
New Jersey, United States
Patent: 209
With the analysis among 193 patents, we discovered top 24 start-ups by total patent application. Phanes Therapeutics, Inc., Cytoimmune Therapeutics, Inc., Systimmune, Inc. are active in this area.
Phanes Therapeutics, Inc.
California, United States
Patent: 31
Cytoimmune Therapeutics, Inc.
California, United States
Patent: 28
Washington, United States
Patent: 20
OriCell Therapeutics Co.,Ltd.
Eucure (Beijing) Biopharma Co., Ltd.
Beijing Shi, China
Patent: 17
Institut National de la Santé et de la Recherche Médicale
Schwyz, Switzerland
Patent: 12
KANAPH Therapeutics, Inc.
Lyvgen Biopharma Co., Ltd
Shanghai Shi, China
Patent: 7
With the analysis among related 4,691 patents applied in the last 5 years. We discover 494 most active companies in this area. The fast-growing F. Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals, Inc., Genmab A/S take 17.86% of patent filing during this period.
F. Hoffmann-La Roche Ltd.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 308
Hovedstaden, Denmark
Patent: 180
California, United States
Patent: 170
Amgen Research (Munich) GmbH
Hessen, Germany
Patent: 118
New York, United States
Patent: 108
California, United States
Patent: 102
Gyeonggi-do, South Korea
Patent: 100
Beijing Hanmei Medicine Co. Ltd.
Beijing Shi, China
Patent: 81
With the analysis among related 4,691 patents in last 5 years, we discover 342 new entrants. ABL Bio, Inc., Innovent Biologics (Suzhou) Co. Ltd., Akeso Biopharma Co., Ltd. are the most active new entrants in this area.
Gyeonggi-do, South Korea
Patent: 100
Innovent Biologics (Suzhou) Co. Ltd.
Jiangsu Sheng, China
Patent: 68
Akeso Biopharma Co., Ltd.
Guangdong Sheng, China
Patent: 37
Phanes Therapeutics, Inc.
California, United States
Patent: 31
California, United States
Patent: 31
WuXi Biologics Ireland Ltd.
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 30
Cytoimmune Therapeutics, Inc.
California, United States
Patent: 28
With the analysis among 874 patents, we discovered top 84 universities and scientific research institutions by total patent application. The Scripps Research Institute, Duke University, The Trustees of Columbia University in The City of New York are dominant in this area. They take 18.31% of the total patent filing.
The Scripps Research Institute
California, United States
Patent: 50
North Carolina, United States
Patent: 36
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 35
Miyagi-ken, Japan
Patent: 25
Ludwig-Maximilians-Universität München
Bayern, Germany
Patent: 23
Eberhard Karls Universität Tübingen
Baden-Württemberg, Germany
Patent: 20
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 15
Louisiana State University
Louisiana, United States
Patent: 12
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 11
Guangdong Sheng, China
Patent: 11